Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/PBH/vs peers

PBHPrestige Consumer Healthcare Inc.vs its industry peers

A metric-by-metric comparison of Prestige Consumer Healthcare Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
CompanyMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
PBHPrestige Consumer Healthcare Inc.This$2.3B#813.9x#31.2x#12.2x#2-4.3%#8-11.3%#728.4%#19.9%#25.9%#24#1-18.2%#8—
BHCBausch Health Companies Inc.$3.0B#1——0.3x#16.7%#7441.3%#117.7%#3—3.7%#3—33.2%#311.7%#1
IDYAIDEAYA Biosciences, Inc.$3.0B#2—2.8x#313.8x#43024.4%#258.6%#3-72.8%#4-10.4%#3——-0.2%#7—
VRDNViridian Therapeutics, Inc.\DE$2.8B#3—4.3x#540.2x#723359.9%#1-26.9%#9-512.9%#8-51.7%#9-54.5%#5—8.6%#6—
NRIXNurix Therapeutics, Inc.$2.8B#410.6x#12.9x#433.6x#654.0%#4-36.6%#10-340.2%#7-27.3%#7——104.8%#2—
MBX$2.7B#5—6.5x#10——-40.5%#11—-21.2%#6————
RCUS$2.4B#6—5.2x#873.0x#9-35.3%#10-24.7%#8-1169.7%#9-76.1%#11-93.0%#8———
BHVN$2.4B#7————12.7%#5——————
IMNMImmunome Inc.$2.3B#9—4.4x#6332.7x#10-23.2%#927.5%#4-3228.8%#10-40.4%#8-72.8%#7—19.4%#4—
XNCRXencor Inc$2.3B#10—4.5x#718.2x#513.7%#660.5%#2-141.4%#6-18.3%#4-31.5%#4—120.4%#1—
VERAVera Therapeutics, Inc.$2.2B#11—5.4x#9——-96.9%#12—-73.5%#10-72.7%#6—18.5%#5—
PVLA$2.2B#12—10.2x#1151.6x#865.3%#3-139.3%#13-90.2%#5-19.2%#5————
HRMY$2.2B#1312.0x#22.2x#22.5x#321.5%#59.1%#624.0%#215.9%#125.5%#14#1——

Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

PBH's peers

BHCIDYAVRDNNRIXMBXRCUSBHVNIMNMXNCRVERAPVLAHRMY
← PBH overview